Liwen Xu

University of Science and Technology of China

Also affiliated with First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Chinese Academy of Fishery Sciences

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients”.

Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients

Science Translational Medicine(2021)10.1126/scitranslmed.abf5264

N/A

0DataRank · unranked

67 citations

Alma‐Martina Cepika, Rajni Agarwal‐Hashmi, Gopin Saini, Molly Javier Uyeda, David M. Louis +17 more

Molecular dynamics of genome editing with CRISPR-Cas9 and rAAV6 virus in human HSPCs to treat sickle cell disease

Molecular Therapy — Methods & Clinical Development(2023)10.1016/j.omtm.2023.07.009

N/A

0DataRank · unranked

12 citations

Premanjali Lahiri, Jason Skowronski, Neehar Bhatia, Annalisa Lattanzi, Matthew H. Porteus +1 more